Your browser doesn't support javascript.
loading
Sex-specific and sex-independent steroid-related biomarkers in early second trimester maternal serum associated with autism.
Bilder, Deborah A; Worsham, Whitney; Sullivan, Scott; Esplin, M Sean; Burghardt, Paul; Fraser, Alison; Bakian, Amanda V.
Affiliation
  • Bilder DA; University of Utah Huntsman Mental Health Institute, 383 Colorow Drive, Room 360, Salt Lake City, UT, 84108, USA. deborah.bilder@hsc.utah.edu.
  • Worsham W; University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Sullivan S; Inova Health System, Falls Church, VA, USA.
  • Esplin MS; University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Burghardt P; Intermountain Healthcare, Salt Lake City, UT, USA.
  • Fraser A; Wayne State University, Detroit, MI, USA.
  • Bakian AV; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
Mol Autism ; 14(1): 30, 2023 08 12.
Article in En | MEDLINE | ID: mdl-37573326
BACKGROUND: Prenatal exposure to maternal metabolic conditions associated with inflammation and steroid dysregulation has previously been linked to increased autism risk. Steroid-related maternal serum biomarkers have also provided insight into the in utero steroid environment for offspring who develop autism. OBJECTIVE: This study examines the link between autism among offspring and early second trimester maternal steroid-related serum biomarkers from pregnancies enriched for prenatal metabolic syndrome (PNMS) exposure. STUDY DESIGN: Early second trimester maternal steroid-related serum biomarkers (i.e., estradiol, free testosterone, total testosterone, and sex hormone binding globulin) were compared between pregnancies corresponding to offspring with (N = 68) and without (N = 68) autism. Multiple logistic regression analyses were stratified by sex and gestational duration. One-way ANCOVA with post hoc tests was performed for groups defined by autism status and PNMS exposure. RESULTS: Increased estradiol was significantly associated with autism only in males (AOR = 1.13 per 100 pg/ml, 95% CI 1.01-1.27, p = 0.036) and only term pregnancies (AOR = 1.17 per 100 pg/ml, 95% CI 1.04-1.32, p = 0.010). Autism status was significantly associated with decreased sex hormone binding globulin (AOR = 0.65 per 50 nmol/L, 95% CI 0.55-0.78, p < 0.001) overall and when stratified by sex and term pregnancy status. The inverse association between sex hormone binding globulin and autism was independent of PNMS exposure. LIMITATIONS: The relative racial and ethnic homogeneity of Utah's population limits the generalizability of study results. Although significant differences by autism status were identified in concentrations of sex hormone binding globulin overall and of estradiol in participant subgroups, differences by PNMS exposure failed to reach statistical significance, which may reflect insufficient statistical power. CONCLUSION: Both elevated maternal serum estradiol in males only and low maternal serum sex hormone binding globulin in both sexes are associated with increased autism risk. Further investigation is merited to identify how steroid, metabolic, and inflammatory processes can interact to influence neurodevelopment in early second trimester.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Sex Hormone-Binding Globulin Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Pregnancy Language: En Journal: Mol Autism Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autistic Disorder / Sex Hormone-Binding Globulin Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Pregnancy Language: En Journal: Mol Autism Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom